Actualités sur Medizin, Gesundheit
- 2plus
DEBIOPHARM AND ASPEN PARTNER TO LAUNCH PROSTATE CANCER DRUG TRELSTAR® IN SOUTH AFRICA
Lausanne, Switzerland and Durban, South Africa (ots) - Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company and Aspen, a South African headquartered multinational pharmaceutical company announced today their partnership to launch Trelstar® (Triptorelin) in South Africa for the treatment of locally advanced and metastatic hormone dependent prostate ...
plusCyberMDX Healthcare Security Suite Release 5.0 Takes on the Ransomware Epidemic
New York (ots/PRNewswire) - Global Healthcare security leader introduces intelligent mitigation actioning into latest release - and launches two new offerings, including the industry's first IoT Security Freemium edition for healthcare organizations who need help now CyberMDX, a leading healthcare cybersecurity provider delivering visibility and threat prevention for ...
plusswissstaffing - Verband der Personaldienstleister der Schweiz
Swiss Staffingindex: Staff leasing sector recovers from impact of coronavirus in 2021
Un documentplusAccord's SONDELBAY ®▼ (teriparatide) is given Green Light by CHMP
Harrow, England (ots/PRNewswire) - Sondelbay – is a self-administered, once-a-day subcutaneous injection for patients with osteoporosis using a pen device - Accord's fourth biosimilar, joins the company's established portfolio across Europe, and marks its first branded product in a new Bone Health franchise representing another great milestone in Accord's growing ...
plusMicreos appoints Joost Goderie as CFO and member of the Board of Directors
The Hague, The Netherlands (ots/PRNewswire) - Micreos announced that it has appointed Joost Goderie to the management board as Chief Financial Officer (CFO). Joost will be working closely together with the other members of the management team to help drive Micreos's growth and deliver its targeted antibacterial technology to the world. He will be responsible for ...
plusKLӦCKNER PENTAPLAST COMMITS TO rPET/PET CAPACITY EXPANSION FOR THE SUSTAINABLE HEALTHCARE AND FOOD PACKAGING MARKET IN NORTH AMERICA
London (ots/PRNewswire) - Klöckner Pentaplast (kp), a global leader in recycled content products and high-barrier protective packaging, has announced its intention to expand its post-consumer recycled content (PCR) PET capacity in North America with a significant investment to further grow its sustainable ...
plusNanoPass's intradermal delivery platform used in Emergex's next generation COVID-19 vaccination study
Nes Ziona, Israel (ots/PRNewswire) - Intradermal COVID-19 vaccination studies are emerging in a global effort to use available doses more effectively by harnessing skin immunity to reduce the dosage required for effective vaccination, as well as to improve the immunogenicity of weaker vaccines. Additionally, there ...
plusHearing loss company Acousia Therapeutics to present data for ACOU085 at ARO 2022 MidWinter Meeting February 5–9
Tübingen (ots) - Acousia Therapeutics GmbH – along with its partners from the Translational Hearing Research Group at the Tübingen Hearing Research Center (Department of Otolaryngology, Head and Neck Surgery, University of Tübingen) and Synovo GmbH (Tübingen) – will be presenting data on the the company’s ...
plusgenOway grants the leading UK academic research funder a non-exclusive license for CRISPR/Cas9 technology
Lyon, France (ots/PRNewswire) - genOway, a world leader in the field of genetically modified innovative research models, announced today that it has granted a non-exclusive CRISPR/Cas9 license to the most important funding institution of biomedical academic research in the United Kingdom. In December 2018, genOway ...
plusSchweizerischer Nationalfonds / Fonds national suisse
Animal experiments and 3R: Interview with animal ethicist Herwig Grimm
plusParity Technologies and MediLedger Network Announce Partnership to Deliver Blockchain-Powered Solutions to the Life Sciences Industry
San Francisco (ots/PRNewswire) - Companies to apply technology originally developed to address drug safety, to pricing accuracy, chargeback automation, and other supply chain solutions Chronicled, the technology company behind MediLedger Network, has entered into a partnership with Parity Technologies, the developer ...
plusZentiva awarded Top Employer accolade
Prague (ots/PRNewswire) - The Top Employee Institute has certified Zentiva as a Top Employer. This prestigious award was received for Zentiva's exceptional standards across 6 Human Resources-domains in its home countries the Czech Republic and Romania. The assessment was covering 20 topics including People Strategy, Work Environment, Talent Acquisition, Learning, Well-being, Diversity & Inclusion, and many more. "I am ...
plusALDER HEY AND NEEDLESMART PARTNERSHIP AIMS TO REDUCE 100,000 NEEDLESTICK INJURIES TO NHS HEALTHCARE WORKERS
plusServier Group Reports Financial Year 2020/2021 Annual Results, R&D Strategy and Pipeline
Paris (ots/PRNewswire) - - Consolidated revenue of €4.725 billion, up +4.3% at constant rates (+0.8% at current rates) - Revenue for brand-name medicines of €3.306 billion +4.8% at constant rates (+0.6% at current rates) and €1.419 billion for the generics +2.9% at constant rates (+1.1% at current rates) - An accelerated oncology strategy with the acquisition of ...
plusOri Biotech raises over $100 million in Series B funding to launch innovative cell and gene therapy manufacturing platform
London (ots/PRNewswire) - Ori Biotech Ltd. (Ori), a leader in cell and gene therapy (CGT) manufacturing technology, today announces it has secured over $100 million in an oversubscribed Series B funding round. The investment round was led by Novalis LifeSciences with Puhua Capital and Chimera Abu Dhabi coming in as ...
plusSchweizerischer Nationalfonds / Fonds national suisse
Animal experiments and 3R: Immune cells live in a complex world
Bern (ots) - Some research relies almost entirely on animal models. An example is the SNSF-funded project on virus surveillance in the mouse brain. "The immune system has a place where it is born, a place where it is educated and a place where it goes to work." Natalia Pikor, research group leader at St. Gallen cantonal hospital, is studying one of the most complicated systems in the bodies of vertebrate animals and ...
plusPoda Lifestyle and Wellness Ltd.
PODA Granted US Patent for Closed Bottom Vaporizer Pod
Vancouver, Bc (ots/PRNewswire) - PODA HOLDINGS, INC. ("Poda" or the "Company") (CSE: PODA) (FSE: 99L) (OTCQB: PODAF) is pleased to announce that it has been granted a US Patent by the US Patent and Trademark Office concerning US Application 16/340,058 for Poda's Closed Bottom Vaporizer Pod. US Patent 11,206,869 B2 was granted on December 28th, 2021. Mr. Ryan Selby, CEO of the Company, commented, "Receiving this Notice of ...
plusDALI Medical's SAN®Light Passive Safety Needle coupled with a novel Drug Product, Enabling User-friendly Administration
Tel Aviv, Israel (ots/PRNewswire) - DALI Medical Devices, an innovative developer and distributor of drug delivery devices, today announced the first commercial implementation of its SAN-Light passive safety needle. SAN-Light was chosen to be used with ADVANZ PHARMA's MYTOLAC®/MYRELEZ® - the first generic ...
plusPoda Lifestyle and Wellness Ltd.
PODA Signs Letter of Intent to Partner with 170-year-old European Tobacco Company - Landewyck Tobacco
Vancouver, Bc (ots/PRNewswire) - PODA HOLDINGS, INC. ("Poda" or the "Company") (CSE: PODA) (FSE: 99L) (OTCQB: PODAF) is pleased to announce that it has signed a letter of intent ("LOI") with Landewyck Tobacco S.A. ("Landewyck") (collectively the "Parties"). In the year 1847, Josephine van Landewyck and Jean-Pierre ...
plusSchweizerischer Nationalfonds / Fonds national suisse
Animal experiments and 3R: mucous membrane as a model
Bern (ots) - In an SNSF-funded project, researchers are studying how bacteria infect the lungs. They are developing an alternative to animal testing that complements existing methods. When bacteria enter our lungs or live in our guts, they physically interact with our own cells that line the openings of our body like a protective layer. Some bacteria help us digest, others make us sick. Alexandre Persat from EPF Lausanne ...
plusPoda Receives Final Approval from OTC Markets to List on the QTCQB
Vancouver, Bc (ots/PRNewswire) - PODA HOLDINGS, INC. ("Poda" or the "Company") (CSE: PODA) (FSE: 99L) (OTC: PODAF) is pleased to announce the Company has received official notification from OTC Markets to up-list from Pink Sheet to the OTCQB tier effective as of January 6, 2022. The OTCQB is a US trading platform that is operated by the OTC Markets Group in New York. The Company will trade on the OTCQB exchange under ...
plusDEBIOPHARM IINVESTS IN VERISIM LIFE’S $15M SERIES A ROUND TO ADVANCE AI-ENABLED DRUG RESEARCH
Lausanne, Switzerland - San Francisco (ots) - Funding to support BIOiSIMTM computational platform to reduce the need for animal testing by selecting compounds showing promise to cure a disease prior to research in humans Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company, announced today their co-investment in California-based start-up VeriSIM Life’s ...
plusVeriSIM Life Secures $15 Million Series A Funding
San Francisco, CA (ots) - Financing led by Morpheus Ventures supports further revenue growth for the company’s next-generation AI platform, redefining the preclinical translational drug development landscape by accurately predicting and accelerating clinical outcomes VeriSIM Life (VeriSIM) www.verisimlife.com, the leading artificial intelligence (AI)-enabled, unique R&D decisions de-risker for breakthrough drug ...
plusSchweizerischer Nationalfonds / Fonds national suisse
Animal experiments and 3R: Wound healing in mice and cell cultures
Bern (ots) - Research projects involving animal experiments employ a variety of methods. An SNSF-funded project on skin diseases, ulcers and cancer exemplifies this. Sabine Werner, professor of cell biology at ETH Zurich, studies how wounds heal. Knowledge of cell and tissue processes helps to better understand, diagnose and treat certain skin diseases. Here the focus is not primarily cuts and abrasions but rather wounds ...
plusAlamar Biosciences partners with Abcam to drive understanding of the human proteome
Fremont, Calif. and Cambridge, England (ots/PRNewswire) - Alamar Biosciences (Alamar), a platform company focused on transforming the field of proteomics to enable the early detection of cancer and other diseases, and Abcam (AIM: ABC) (NASDAQ: ABCM), a global innovator in life sciences research tools, today announced a strategic partnership to further understanding of ...
plusEssence Group Announces Success in Meeting Supply Demand Throughout 2021, Despite Major Chip Shortages Caused by Ongoing COVID-19 Disruption
Herzliya, Israel (ots/PRNewswire) - Efficient Supply Chain Management, Including Advanced Forecasting and Component Sourcing, Resulted in Essence's 99.5% On-Time Delivery of Customer Orders Essence Group, a leading technology group developing IoT-based security, safety and healthcare solutions and cloud services for ...
plusSchweizerischer Nationalfonds / Fonds national suisse
Gut bacteria linked to infant sleep patterns
Bern (ots) - A study funded by the Swiss National Science Foundation shows that the link between sleep behaviour and intestinal flora is already present in infancy. The gut flora of infants is connected to their sleep patterns. This effect is evident from the age of three months, as sleep researchers Salome Kurth of the University of Fribourg and Sarah Schoch of the University of Zurich have now shown. For example, ...
plusCardiovascular Startup, Filterlex Medical, Selected to Receive €7M from the European Innovation Council
Caesarea, Israel (ots/PRNewswire) - Filterlex Medical, a cardiovascular medical device startup, announced today that it has been selected to receive €7 Million equity investment from the European Innovation Council Accelerator (EIC). The EIC equity investment will be a part of Filterlex's next round of financing. ...
plusNovaliq Announces POSITIVE Topline Results for SECOND PHASE 3 TRIAL (ESSENCE-2) of CyclASol® in Dry Eye Disease
Heidelberg, Germany and Cambridge, Mass (ots/PRNewswire) - Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology, today announced key results of the second pivotal Phase 3 trial (ESSENCE-2) evaluating the investigational drug ...
plus